drug patents
Medicine exclusivity rights
Drug patents are exclusive rights granted to pharmaceutical companies for new medications, typically lasting twenty years from filing.
During this period, no competitor may manufacture or sell the drug, allowing the patent holder to set prices without generic competition.
The drug patent expires next year, so cheaper versions will flood the market.
Patent extensions and related strategies—sometimes called evergreening—can prolong exclusivity beyond the original term.
- biopharmaceuticalsMedicines derived from living sources
- blockbuster drugsExtremely high-revenue pharmaceuticals
- clinical trialsControlled health research experiments
- pricing strategiesMethods for setting charges
- FDA approvalOfficial drug safety certification
cost-benefit analysis · research funding · Pfizer · expiration · pricing · FDA · protection · monopoly · royalties · molecule · exclusivity · trademark · healthcare costs · licensing · innovation · blockbuster · branded · billion
- Drug RegulationFDA, DEA, controlled substances, Schedule II, FDA approval
- Health Regulationmedical devices, product recalls, health warnings, prescription drugs, over-the-counter drugs
- pharmacy historyapothecary, druggist, pharmacopoeia, compounding, apothecaries
- biopatents
- drug patentsexclusivity, generics, generic drugs, biologics, biosimilars
- patentspatents, USPTO, EPO, PCT, pharmaceutical patents